Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
As of today, Incyte(INCY) shares are valued at $107.91. The company's market cap stands at 21.31B, with a P/E ratio of 18.18.
On 2026-02-09, Incyte(INCY) stock moved within a range of $103.29 to $108.52. With shares now at $107.91, the stock is trading +4.5% above its intraday low and -0.6% below the session's peak.
Trading volume for Incyte(INCY) stock has reached 2.19M, versus its average volume of 1.73M.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $112.29 and a low of $53.56.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $112.29 and a low of $53.56.
INCY News
Piper Sandler analyst Allison Bratzel raised the firm’s price target on Incyte (INCY) to $110 from $102 and keeps an Overweight rating on the shares. Following...
In late January 2026, Incyte reported that the EMA’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Zynyz (re...
Incyte (INCY) has received a new Buy rating, initiated by H.C. Wainwright analyst, Mitchell Kapoor. Claim 50% Off TipRanks Premium Unlock hedge fund-level data...
Analyst ratings
48%
of 29 ratingsMore INCY News
H.C. Wainwright initiated coverage of Incyte (INCY) with a Buy rating and $135 price target The current share price reflects Jakafi loss of exclusivity concerns...
If you are wondering whether Incyte's current share price lines up with its underlying worth, you are not alone. This article is designed to help you connect th...
Incyte (INCY) announced an update on their ongoing clinical study. Tafasitamab-Parsaclisib Basket Trial Halted A Phase 1b/2a basket trial titled “A Phase 1b/2...
Advertisement Context for Incyte’s recent share performance Incyte (INCY) has been trading quietly. The stock is down around 1% over the past week and past mo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.